Amgen Says ERISA Anemia Drug Claims Lack Merit
Amgen Inc. says there is no merit to a consolidated class action accusing it of violating the Employee Retirement Income Security Act by making false statements about sales growth projections for...To view the full article, register now.
Already a subscriber? Click here to view full article